Cohort Studyhigh evidence
Comparison of [18F]flortaucipir and [18F]MK6240 for the detection of tau pathology in Alzheimer's disease (HEAD): a multicentre, prospective, cross-sectional, within-participant study.
Lancet (London, England)·May 30, 2026·PMID 42208563
Why it mattersTracer selection significantly affects tau detection rates, which has direct implications for patient selection in clinical trials and for interpreting tau PET results in diagnostic and therapeutic decision-making.
![Infographic summary of Comparison of [18F]flortaucipir and [18F]MK6240 for the detection of tau pathology in Alzheimer's disease (HEAD): a multicentre, prospective, cross-sectional, within-participant study.](https://mhmngeqdeffyatyoopob.supabase.co/storage/v1/object/public/infographics/87f21b0e-2eb7-44a4-b148-5341b0b01700/b2dc6581-3d0c-4b25-8682-e64de7de2473.png)
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled